“Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation” (2023) Biomolecules and Biomedicine, 23(2), pp. 259–270. doi:10.17305/bjbms.2022.8034.